Combining them in one pen means a single device and one COA instead of two separate products
Key Points Indian pharma companies launched branded semaglutide generics after patent expiry, unlocking a fast-growing diabetes and obesity treatment market
Each consultation covers full medical history, potential contraindications, and metabolic screening before any prescription is written
Overall, both classes are indifferently recommended by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) as first-line therapy in patients with T2DM and established ASCVD or multiple ASCVD risk factors to reduce the risk of major adverse cardiovascular events (MACE), such as myocardial infarction, stroke, and cardiovascular death [6, 7]
Cancer / proliferation concern: Potentiating c-Met (a proto-oncogene product) raises a legitimate theoretical risk of promoting pre-existing or nascent malignancy